Phillip Samayoa

Phillip Samayoa

Chief Tech/Sci/R&D Officer at GENERATION BIO CO.
39 year
Health Technology
Finance
Industrial Services

Profile

Phillip Samayoa is the founder of Dyne Therapeutics, Inc. (2017) and Codiak BioSciences, Inc. (2014).
Dr. Samayoa is currently the Chief Scientific Officer at Generation Bio Co. since 2025.
Former jobs include Director at Merck Research Ventures Fund, Principal at Merck & Co., Inc. (2016), Principal at Atlas Venture Advisors, Inc. (2016-2018), Associate at Flagship Pioneering, Inc., Principal at Bayer Technology Services GmbH, Principal at Infinity Pharmaceuticals, Inc., and Principal at Decision Resources, Inc. Education includes an undergraduate degree from the Massachusetts Institute of Technology (2009) and a doctorate from the University of California San Diego (2012).

Phillip Samayoa active positions

CompaniesPositionStart
GENERATION BIO CO. Chief Tech/Sci/R&D Officer 10/01/2025

Former positions of Phillip Samayoa

CompaniesPositionEnd
Private Equity Investor 31/01/2018
DYNE THERAPEUTICS, INC. Founder 01/01/2018
MERCK & CO., INC. Corporate Officer/Principal 30/06/2016
CODIAK BIOSCIENCES Founder 31/03/2015
Director/Board Member -
See the detail of Phillip Samayoa's experience

Training of Phillip Samayoa

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

87

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Finance

Finance

Industrial Services

Health Technology

Finance

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Phillip Samayoa